Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss MIRM Mirum Pharmaceuticals reports steep Q4 2025 EPS miss while shares post a small gain in todays trading SBSW DBA posts 254 percent Q2 2022 EPS miss shares jump 1468 percent on strong investor sentiment IGR CBRE flags steady demand for high quality commercial real estate assets in its latest quarterly earnings release Amrize AMRZ Stock Risk Factors Breakdown Q1 2026 Below Expectations Johnson Johnson JNJ Bullish Fundamental Catalysts and Sector Value Opportunity Amid Broad Healthcare Outflows What ICU Medical ICUI is building for next year Q4 2025 Earnings Beat Estimates Agnico Eagle Mines Limited AEM Q1 2026 Earnings Top Consensus Estimates Amid Mixed Operational Performance